Literature DB >> 21256151

Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?

Felipe F Tuon, Andrea M Rymsza, Sergio R Penteado-Filho, Marcelo Pilonetto, Lavinia N Arend, Anna S Levin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256151     DOI: 10.1016/j.jinf.2011.01.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

1.  Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections.

Authors:  A C Tonacio; M S Oliveira; L M S Malbouisson; A S Levin
Journal:  Infection       Date:  2013-10-30       Impact factor: 3.553

2.  Microbiological profile and susceptibility pattern of surgical site infections related to orthopaedic trauma.

Authors:  Felipe Francisco Tuon; Juliette Cieslinski; Ana Flávia Miyazaki Ono; Fernanda Lie Goto; Julia Maria Machinski; Letícia Kist Mantovani; Liliana Ramirez Kosop; Maisa Sayuri Namba; Jaime Luis Rocha
Journal:  Int Orthop       Date:  2018-08-02       Impact factor: 3.075

3.  Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.

Authors:  Todd A Miano; Ebbing Lautenbach; F Perry Wilson; Wensheng Guo; Yuliya Borovskiy; Sean Hennessy
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 8.237

4.  Trend analysis of carbapenem-resistant Gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era: an extra challenge for healthcare institutions.

Authors:  V M de Carvalho Hessel Dias; F Tuon; P de Jesus Capelo; J P Telles; C M C B Fortaleza; C Pellegrino Baena
Journal:  J Hosp Infect       Date:  2021-11-19       Impact factor: 3.926

5.  A simple mathematical model to determine the ideal empirical antibiotic therapy for bacteremic patients.

Authors:  Felipe F Tuon; Jaime L Rocha; Talita M Leite; Camila Dias
Journal:  Braz J Infect Dis       Date:  2014-03-01       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.